AssetMark Inc’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
CAMG
ECM
BP
RBI
OAM
KCM
AssetMark Inc's CLB Position: Q2 2026 in Review
AssetMark Inc reduced its Core Laboratories (CLB) stake by 63% in Q2 2026, selling an estimated $7.28K and leaving 298 shares worth $3.47K. The position accounts for ﹤0.01% of the portfolio, ranked #2810.
AssetMark Inc first reported a position in CLB in Q3 2015 and has held it in 26 quarters since. The position peaked at $86.7K in Q2 2025. 55 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- AssetMark Inc held 298 shares of Core Laboratories worth $3.47K as of Q2 2026.
- AssetMark Inc sold 510 Core Laboratories shares in Q2 2026, an estimated $7.28K.
- Core Laboratories made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #2810 holding.
- AssetMark Inc first reported a position in Core Laboratories in Q3 2015 and has held it in 26 quarters since.
- AssetMark Inc's Core Laboratories position peaked at $86.7K in Q2 2025.
- 55 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.